PL356774A1 - Sposób wytwarzania kwasu 6-(4-chlorofenylo)-2,2-dimetylo-7-fenylo-2,3-dihydro-1H-pirolizyn-5-yloctowego - Google Patents

Sposób wytwarzania kwasu 6-(4-chlorofenylo)-2,2-dimetylo-7-fenylo-2,3-dihydro-1H-pirolizyn-5-yloctowego

Info

Publication number: PL356774A1
Authority: PL; Poland
Prior art keywords: compound; formula; pyrrolizine; chlorophenyl; dihydro
Prior art date: 2000-01-28

Application number

PL01356774A

Other languages

English (en)

Other versions

PL208027B1 (pl

Inventor

Thomas Kammermeier

Stefan Laufer

Philipp Merckle

Hans-Gunter Striegel

Original Assignee

Merckle Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-28

Filing date

2001-01-26

Publication date

2004-07-12

2000-01-28 Priority claimed from MXPA/A/2000/001047A external-priority patent/MXPA00001047A/xx

2001-01-26 Application filed by Merckle Gmbh filed Critical Merckle Gmbh

2004-07-12 Publication of PL356774A1 publication Critical patent/PL356774A1/pl

2011-03-31 Publication of PL208027B1 publication Critical patent/PL208027B1/pl

Links

UAWXGRJVZSAUSZ-UHFFFAOYSA-N licofelone Chemical compound OC(=O)CC=1N2CC(C)(C)CC2=C(C=2C=CC=CC=2)C=1C1=CC=C(Cl)C=C1 UAWXGRJVZSAUSZ-UHFFFAOYSA-N 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 4
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 abstract 2
239000012071 phase Substances 0.000 abstract 2
150000008044 alkali metal hydroxides Chemical class 0.000 abstract 1
239000008346 aqueous phase Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Oncology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL356774A 2000-01-28 2001-01-26 Sposób wytwarzania kwasu 6-(4-chlorofenylo)-2,2-dimetylo-7-fenylo-2,3-dihydro-1H-pirolizyn-5-yloctowego, związek pośredni, kwas 6-(4-chlorofenylo)-2, 2-dimetylo-7-fenylo-2, 3-dihydro-1H-pirolizyn-5-yloctowy, środek farmaceutyczny i zastosowanie tego kwasu PL208027B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
MXPA/A/2000/001047A MXPA00001047A (en)		2000-01-28	Method for producing 6-(4-chlorophenyl) -2,2-dimethyl-7- phenyl -2,3-dihydro- 1h-pyrrolizine- 5-yl acetic acid

Publications (2)

Publication Number	Publication Date
PL356774A1 true PL356774A1 (pl)	2004-07-12
PL208027B1 PL208027B1 (pl)	2011-03-31

Family

ID=32589023

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL356774A PL208027B1 (pl)	2000-01-28	2001-01-26	Sposób wytwarzania kwasu 6-(4-chlorofenylo)-2,2-dimetylo-7-fenylo-2,3-dihydro-1H-pirolizyn-5-yloctowego, związek pośredni, kwas 6-(4-chlorofenylo)-2, 2-dimetylo-7-fenylo-2, 3-dihydro-1H-pirolizyn-5-yloctowy, środek farmaceutyczny i zastosowanie tego kwasu

Country Status (30)

Country	Link
US (1)	US6417371B1 (pl)
EP (1)	EP1252164B1 (pl)
JP (1)	JP5143326B2 (pl)
KR (1)	KR100749222B1 (pl)
CN (1)	CN1160357C (pl)
AT (1)	ATE262529T1 (pl)
AU (1)	AU779616B2 (pl)
BG (1)	BG65567B1 (pl)
BR (1)	BR0107898A (pl)
CA (1)	CA2397767C (pl)
CU (1)	CU23193A3 (pl)
DE (1)	DE50101761D1 (pl)
DK (1)	DK1252164T3 (pl)
EA (1)	EA004938B1 (pl)
EE (1)	EE05125B1 (pl)
ES (1)	ES2218382T3 (pl)
GE (1)	GEP20043408B (pl)
HR (1)	HRP20020707B1 (pl)
HU (1)	HUP0300604A3 (pl)
IS (1)	IS2404B (pl)
NZ (1)	NZ520429A (pl)
PL (1)	PL208027B1 (pl)
PT (1)	PT1252164E (pl)
RS (1)	RS50374B (pl)
SK (1)	SK286608B6 (pl)
TR (1)	TR200400691T4 (pl)
TW (1)	TWI289561B (pl)
UA (1)	UA72580C2 (pl)
WO (1)	WO2001055149A1 (pl)
ZA (1)	ZA200206832B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10141285A1 (de) *	2001-08-23	2003-03-27	Merckle Gmbh	Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
DE102005012971A1 (de) *	2005-03-21	2006-09-28	Merckle Gmbh	Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
WO2007108006A1 (en) *	2006-03-23	2007-09-27	Unichem Laboratories Limited	Process for the preparation of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2, 3-dihydro-1h-pyrrolizin-5-yl acetic acid and its intermediates
ES2534772T3 (es) *	2008-10-31	2015-04-28	C-A-I-R Biosciences Gmbh	Sal de colina y trometamina de licofelona
WO2017015013A1 (en) *	2015-07-17	2017-01-26	The Board Of Regents Of The University Of Oklahoma	Licofelone derivatives and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5260451A (en)	1989-05-11	1993-11-09	Merckle Gmbh	Substituted pyrrole compounds and use thereof in pharmaceutical compositions
DE3915450A1 (de) *	1989-05-11	1990-11-15	Gerd Prof Dr Dannhardt	Substituierte pyrrolverbindungen und deren anwendung in der pharmazie
DE4419246A1 (de)	1994-06-01	1995-12-07	Merckle Gmbh	Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419247A1 (de)	1994-06-01	1995-12-07	Merckle Gmbh	Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
DE4419315A1 (de) *	1994-06-01	1995-12-07	Merckle Gmbh	Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie

2001
- 2001-01-26 EE EEP200200417A patent/EE05125B1/xx not_active IP Right Cessation
- 2001-01-26 RS YUP-565/02A patent/RS50374B/sr unknown
- 2001-01-26 EA EA200200740A patent/EA004938B1/ru not_active IP Right Cessation
- 2001-01-26 ES ES01905691T patent/ES2218382T3/es not_active Expired - Lifetime
- 2001-01-26 NZ NZ520429A patent/NZ520429A/en not_active IP Right Cessation
- 2001-01-26 HU HU0300604A patent/HUP0300604A3/hu unknown
- 2001-01-26 UA UA2002086986A patent/UA72580C2/uk unknown
- 2001-01-26 PL PL356774A patent/PL208027B1/pl unknown
- 2001-01-26 DK DK01905691T patent/DK1252164T3/da active
- 2001-01-26 CN CNB01804235XA patent/CN1160357C/zh not_active Expired - Fee Related
- 2001-01-26 EP EP01905691A patent/EP1252164B1/de not_active Expired - Lifetime
- 2001-01-26 CA CA002397767A patent/CA2397767C/en not_active Expired - Fee Related
- 2001-01-26 JP JP2001561008A patent/JP5143326B2/ja not_active Expired - Fee Related
- 2001-01-26 US US09/769,742 patent/US6417371B1/en not_active Expired - Lifetime
- 2001-01-26 SK SK1043-2002A patent/SK286608B6/sk not_active IP Right Cessation
- 2001-01-26 WO PCT/EP2001/000852 patent/WO2001055149A1/de not_active Ceased
- 2001-01-26 HR HR20020707A patent/HRP20020707B1/xx not_active IP Right Cessation
- 2001-01-26 KR KR1020027009706A patent/KR100749222B1/ko not_active Expired - Fee Related
- 2001-01-26 DE DE50101761T patent/DE50101761D1/de not_active Expired - Lifetime
- 2001-01-26 BR BR0107898-4A patent/BR0107898A/pt not_active Application Discontinuation
- 2001-01-26 TR TR2004/00691T patent/TR200400691T4/xx unknown
- 2001-01-26 GE GE4919A patent/GEP20043408B/en unknown
- 2001-01-26 AT AT01905691T patent/ATE262529T1/de active
- 2001-01-26 AU AU33711/01A patent/AU779616B2/en not_active Ceased
- 2001-01-26 PT PT01905691T patent/PT1252164E/pt unknown
- 2001-05-09 TW TW090111072A patent/TWI289561B/zh not_active IP Right Cessation
2002
- 2002-07-17 CU CU20020150A patent/CU23193A3/es not_active IP Right Cessation
- 2002-07-19 IS IS6475A patent/IS2404B/is unknown
- 2002-07-24 BG BG106951A patent/BG65567B1/bg unknown
- 2002-08-27 ZA ZA200206832A patent/ZA200206832B/en unknown

Also Published As

Publication number	Publication date
EE05125B1 (et)	2009-02-16
CN1396922A (zh)	2003-02-12
ZA200206832B (en)	2003-10-07
TWI289561B (en)	2007-11-11
HUP0300604A3 (en)	2003-10-28
EE200200417A (et)	2003-12-15
JP5143326B2 (ja)	2013-02-13
TR200400691T4 (tr)	2004-11-22
IS6475A (is)	2002-07-19
IS2404B (is)	2008-09-15
BG65567B1 (bg)	2008-12-30
UA72580C2 (en)	2005-03-15
RS50374B (sr)	2009-11-10
HK1047590A1 (en)	2003-02-28
CA2397767A1 (en)	2001-08-02
US20020028953A1 (en)	2002-03-07
WO2001055149A1 (de)	2001-08-02
CU23193A3 (es)	2007-03-23
YU56502A (sh)	2005-06-10
EA200200740A1 (ru)	2002-12-26
HUP0300604A2 (hu)	2003-07-28
CN1160357C (zh)	2004-08-04
JP2004517799A (ja)	2004-06-17
BG106951A (en)	2003-07-31
NZ520429A (en)	2003-08-29
US6417371B1 (en)	2002-07-09
HRP20020707B1 (en)	2006-05-31
BR0107898A (pt)	2002-11-05
HRP20020707A2 (en)	2004-12-31
EP1252164A1 (de)	2002-10-30
PT1252164E (pt)	2004-08-31
GEP20043408B (en)	2004-06-10
AU779616B2 (en)	2005-02-03
KR100749222B1 (ko)	2007-08-13
ES2218382T3 (es)	2004-11-16
KR20020075895A (ko)	2002-10-07
EA004938B1 (ru)	2004-10-28
PL208027B1 (pl)	2011-03-31
ATE262529T1 (de)	2004-04-15
EP1252164B1 (de)	2004-03-24
SK286608B6 (sk)	2009-02-05
SK10432002A3 (sk)	2003-02-04
AU3371101A (en)	2001-08-07
DK1252164T3 (da)	2004-07-05
CA2397767C (en)	2008-05-06
DE50101761D1 (de)	2004-04-29

Legal Events

Date	Code	Title	Description
2012-02-29	RECP	Rectifications of patent specification

Publication	Publication Date	Title
NZ594077A (en)	2013-02-22	Process for production of delta-9-tetrahydrocannabinol
YU66003A (sh)	2006-05-25	Postupak za izdvajanje hemiceluloza iz biomase koja sadrži hemiceluloze kao i biomasa i hemiceluloze koje se mogu dobiti primenom ovog postupka
EP1253130A3 (en)	2003-10-15	Method for producing 3-l-menthoxypropane-1,2-diol
SG151330A1 (en)	2009-04-30	Process for production of optically active amine derivatives
AU7090601A (en)	2002-02-05	Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid
PL356774A1 (pl)	2004-07-12	Sposób wytwarzania kwasu 6-(4-chlorofenylo)-2,2-dimetylo-7-fenylo-2,3-dihydro-1H-pirolizyn-5-yloctowego
MY128460A (en)	2007-02-28	Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
ATE71937T1 (de)	1992-02-15	Verfahren zur herstellung von octahydroindolderivaten und ihre zwischenprodukte.
ATE329900T1 (de)	2006-07-15	Verfahren zur herstellung von 2-pyrrolidon
PY0109408A (es)	2003-11-03	Proceso para preparar acido 6-(4-clorofenil)-2,2-dimetil-7-fenil-2,3-dihidro-1 h 0 pirrolizin-5-ilacetico
AU2018101865A4 (en)	2019-01-24	Coordination agent trichloromethyl benzyl acetate production plant
BR0100689A (pt)	2001-09-25	Fabricação de ácido cìclico
CN104356155B (zh)	2017-01-18	一种(s)‑叔丁基二甲基硅氧基‑戊二酸单酰胺的制备方法
CN105541688A (zh)	2016-05-04	一种合成高浓度无水过氧乙酸溶液联产乙酰脲的方法
ATE425972T1 (de)	2009-04-15	Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
NL2031389B1 (en)	2023-10-06	METHOD FOR PREPARING a-CARBONYL BUTYRAMIDE THROUGH REACTION IN WATER PHASE
GEP20074025B (en)	2007-01-25	Process for preparing acid salts of gemifloxacin
UY26708A1 (es)	2001-07-31	Proceso para preparar ácido 6 - (4 - clorofenil) - 2, 2 - dimetil - 7 - fenil - 2, 3 - dihidro - 1 h - pirrolizin - 5 - ilacético.
JP2009062392A (ja)	2009-03-26	環化法
CO5280193A1 (es)	2003-05-30	Proceso para preparar acido 6-(4-clorofenil)-2,2-dimetil-7- fenil-2,3-dihidro-1h-pirrolizin-5-il acetico
EP1798235A4 (en)	2009-08-12	ACIDIC ACID SALT OF IRINOTECAN
UA87995C2 (ru)	2009-09-10	Способ получения высокочистого свободного от галогенов о-фталальдегида
UA84150C2 (ru)	2008-09-25	Йодопиразолилкарбоксанилиды, способ их получения, производные йодопиразолилкарбоновой кислоты и средство для борьбы с нежелательными микроорганизмами
JPH1135576A (ja)	1999-02-09	３−アルキルフラバノノール誘導体の製造方法
WO2003042193A1 (en)	2003-05-22	Process for preparing 5-methylisoxazole-4-carboxylic-(4'-trifluoromethyl)-anilide